Elder
-
BiondVax’s universal flu vaccine improves existing flu vaccines in elderly
BiondVax Pharmaceuticals announced positive results from its second Phase II clinical trial (BVX-005) of the Universal Influenza Vaccine (Multimeric-001) developed by Biondvax for improving existing flu vaccines in elderly.
Elder | 20 February 2012
-
Elder Pharmaceuticals to Increase Sales Force in India
With major thrust on the rural markets and plans to launch more products (owned and in-licensed) in FY 2011 across India, Elder Pharmaceuticals plans to increase its sales and marketing force headcount by about 1,000. Elder presently employs abou…
Elder | 23 April 2010
-
Elder Pharma Hikes Stake In Bulgarian Acquisition
Elder Pharmaceuticals has extended its control over its Bulgarian acquisitions by hiking stake in its subsidiary Elder Biomeda to 61 percent from the present 51 percent for an undisclosed sum. The balance 39 percent stake in Elder Biomeda is held by …
Elder | 24 March 2010
-
Elder Pharmaceuticals Moves Operations
Mumbai-based, Elder Pharmaceuticals has commenced commercial operations at its US Food and Drug Administration (FDA) compliant manufacturing facility, located in Uttarakhand. The company plans to move to this facility, the manufacture of all syru…
Elder | 17 February 2010
-
Elder Pharmaceuticals to Tap Rural Markets in India
Elder Pharmaceuticals has set up a division called “Elvista†to spread its network to villages, towns, sub-urban/periphery markets and hinterland districts. The initial target is Class II to IV towns and rural markets with a dedicated sales force…
Elder | 27 July 2009
